Onco-Pathogen mediated cancer progression and associated signaling pathways in cancer development
S Kannampuzha, AV Gopalakrishnan, H Padinharayil… - Pathogens, 2023 - mdpi.com
Infection with viruses, bacteria, and parasites are thought to be the underlying cause of
about 8–17% of the world's cancer burden, ie, approximately one in every five malignancies …
about 8–17% of the world's cancer burden, ie, approximately one in every five malignancies …
Non-HIV Kaposi's sarcoma: a review and therapeutic perspectives
Y Akasbi, A Awada, S Arifi, N Mellas, O El Mesbahi - Bulletin du cancer, 2012 - Elsevier
Abstract “Classic” Kaposi's sarcoma (CKS) not related to HIV is a multifocal
angioproliferative neoplasm that is linked to human herpesvirus. CKS is a cutaneous cancer …
angioproliferative neoplasm that is linked to human herpesvirus. CKS is a cutaneous cancer …
[HTML][HTML] Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity
E Sei, NK Conrad - Virology, 2011 - Elsevier
The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is an essential
multifunctional regulator of gene expression. ORF57 interaction with RNA is necessary for …
multifunctional regulator of gene expression. ORF57 interaction with RNA is necessary for …
Virus–host interplay between poly (ADP-ribose) polymerase 1 and oncogenic gammaherpesviruses
The gammaherpesviruses, include the Epstein–Barr virus, Kaposi's sarcoma-associated
herpesvirus, and murine gammaherpesvirus 68. They establish latent infection in the B …
herpesvirus, and murine gammaherpesvirus 68. They establish latent infection in the B …
Upregulation of microRNA 711 mediates HIV-1 Vpr promotion of Kaposi's sarcoma-associated herpesvirus latency and induction of pro-proliferation and pro-survival …
Q Yan, R Zhao, C Shen, F Wang, W Li, SJ Gao… - Journal of …, 2018 - Am Soc Microbiol
Coinfection with HIV-1 and Kaposi's sarcoma-associated herpesvirus (KSHV) often leads to
AIDS-related malignancies, including Kaposi's sarcoma (KS) and primary effusion …
AIDS-related malignancies, including Kaposi's sarcoma (KS) and primary effusion …
[HTML][HTML] KSHV LANA upregulates the expression of epidermal growth factor like domain 7 to promote angiogenesis
S Thakker, RC Strahan, AN Scurry, T Uppal… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Kaposi's sarcoma (KS) is a highly-vascularized tumor characterized by inflammation and
extensive neo-angiogenesis. The KS tumor microenvironment is rich in inflammatory and …
extensive neo-angiogenesis. The KS tumor microenvironment is rich in inflammatory and …
Activation and counteraction of antiviral innate immunity by KSHV: an Update
X Wei, K Lan - Science bulletin, 2018 - Elsevier
The innate immune responses triggering production of type I interferons and inflammatory
cytokines constitute a nonspecific innate resistance that eliminates invading pathogens …
cytokines constitute a nonspecific innate resistance that eliminates invading pathogens …
Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats
P Purushothaman, ME McDowell… - Journal of …, 2012 - Am Soc Microbiol
The latency-associated nuclear antigen (LANA) encoded by Kaposi's sarcoma-associated
herpesvirus (KSHV) plays a major role in maintaining latency and is critical for the perpetual …
herpesvirus (KSHV) plays a major role in maintaining latency and is critical for the perpetual …
Kaposi's sarcoma-associated herpesvirus infection induces the expression of neuroendocrine genes in endothelial cells
Kaposi's sarcoma-associated herpesvirus (KSHV) is etiologically associated with
endothelial Kaposi's sarcoma (KS) in immunocompromised individuals. KS lesion cells …
endothelial Kaposi's sarcoma (KS) in immunocompromised individuals. KS lesion cells …
Regulation of the metastasis suppressor Nm23-H1 by tumor viruses
Metastasis is the most common cause of cancer mortality. To increase the survival of
patients, it is necessary to develop more effective methods for treating as well as preventing …
patients, it is necessary to develop more effective methods for treating as well as preventing …